Home
Scholarly Works
Early Metformin in Gestational Diabetes
Journal article

Early Metformin in Gestational Diabetes

Abstract

(Abstracted from JAMA 2023;330(16):1547–1556 Worldwide, about 2.93 million pregnancies are complicated by gestational diabetes mellitus (GDM) annually. GDM is associated with an increased risk of maternal adverse outcomes, such as weight gain, cesarean delivery (CD), and preeclampsia, as well as fetal adverse outcomes, such as admission to the neonatal intensive care unit (NICU) due to birth injuries and respiratory disease.

Authors

Dunne F; Newman C; Alvarez-Iglesias A; Ferguson J; Smyth A; Browne M; O’Shea P; Devane D; Gillespie P; Bogdanet D

Journal

Obstetrical & Gynecological Survey, Vol. 79, No. 4, pp. 193–195

Publisher

Wolters Kluwer

Publication Date

April 1, 2024

DOI

10.1097/01.ogx.0001016668.98870.2b

ISSN

0029-7828

Contact the Experts team